|
TWI329105B
(en)
|
2002-02-01 |
2010-08-21 |
Rigel Pharmaceuticals Inc |
2,4-pyrimidinediamine compounds and their uses
|
|
HRP20050089B1
(hr)
|
2002-07-29 |
2015-06-19 |
Rigel Pharmaceuticals |
Upotreba 2,4 pirimidindiaminskog spoja za proizvodnju lijeka za lijeäśenje ili sprjeäśavanje autoimunosne bolesti
|
|
WO2005012294A1
(en)
|
2003-07-30 |
2005-02-10 |
Rigel Pharmaceuticals, Inc. |
2,4-pyrimidinediamine compounds for use in the treatment or prevention of autoimmune diseases
|
|
ATE506953T1
(de)
*
|
2003-08-07 |
2011-05-15 |
Rigel Pharmaceuticals Inc |
2,4-pyrimidindiamin-verbindungen und verwendungen als antiproliferative mittel
|
|
PT1660458E
(pt)
*
|
2003-08-15 |
2012-04-27 |
Novartis Ag |
2,4-pirimidinodiaminas úteis no tratamento de doenças neoplásicas, desordens inflamatórias e do sistema imunitário
|
|
US20070105839A1
(en)
*
|
2003-09-18 |
2007-05-10 |
Patricia Imbach |
2, 4-Di (phenylamino) pyrimidines useful in the treatment of proliferative disorders
|
|
US7754714B2
(en)
*
|
2004-05-18 |
2010-07-13 |
Rigel Pharmaceuticals, Inc. |
Cycloalkyl substituted pyrimidinediamine compounds and their uses
|
|
GB2420559B
(en)
*
|
2004-11-15 |
2008-08-06 |
Rigel Pharmaceuticals Inc |
Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses
|
|
SI1814878T1
(sl)
|
2004-11-24 |
2012-06-29 |
Rigel Pharmaceuticals Inc |
Spojine spiro-2,4-pirimidindiamina in njihova uporaba
|
|
AU2006206458B2
(en)
|
2005-01-19 |
2012-10-25 |
Rigel Pharmaceuticals, Inc. |
Prodrugs of 2,4-pyrimidinediamine compounds and their uses
|
|
US8227455B2
(en)
|
2005-04-18 |
2012-07-24 |
Rigel Pharmaceuticals, Inc. |
Methods of treating cell proliferative disorders
|
|
AU2006241825A1
(en)
|
2005-04-28 |
2006-11-09 |
Mitsubishi Tanabe Pharma Corporation |
Cyanopyridine derivative and use thereof as medicine
|
|
EP1883302A4
(en)
*
|
2005-05-03 |
2009-05-20 |
Rigel Pharmaceuticals Inc |
JAK KINASE HEMMER AND ITS USE
|
|
US20070203161A1
(en)
*
|
2006-02-24 |
2007-08-30 |
Rigel Pharmaceuticals, Inc. |
Compositions and methods for inhibition of the jak pathway
|
|
US7417066B2
(en)
|
2005-06-08 |
2008-08-26 |
Schering Ag |
Inhibitors of soluble adenylate cyclase
|
|
DE102005027274A1
(de)
*
|
2005-06-08 |
2006-12-14 |
Schering Ag |
Inhibitoren der löslichen Adenylatzyklase
|
|
BRPI0610876B8
(pt)
|
2005-06-08 |
2021-05-25 |
Rigel Pharmaceuticals Inc |
composto, formulação farmacêutica, e métodos de inibir uma atividade de uma jak cinase, e de inibir uma cascata de transdução de sinal em que jak3 cinase desempenha um papel
|
|
JP2008543855A
(ja)
|
2005-06-13 |
2008-12-04 |
ライジェル ファーマシューティカルズ， インコーポレイテッド |
変形性骨疾患を処置するための方法および組成物
|
|
ATE352714T1
(de)
*
|
2005-06-17 |
2007-02-15 |
Magneti Marelli Powertrain Spa |
Brennstoffeinspritzventil
|
|
EP1904479A2
(fr)
*
|
2005-07-11 |
2008-04-02 |
Sanofi-Aventis |
Nouveaux derives de 2,4-dianilinopyrimidines, leur preparation, a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk
|
|
FR2888239B1
(fr)
*
|
2005-07-11 |
2008-05-09 |
Sanofi Aventis Sa |
Nouveaux derives de 2,4-dianilinopyrimidines, leur preparation, a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk
|
|
US8372851B2
(en)
|
2005-10-21 |
2013-02-12 |
Exelixis, Inc. |
Pyrazolo pyrimidines as casein kinase II (CK2) modulators
|
|
US7659280B2
(en)
|
2006-02-17 |
2010-02-09 |
Rigel Pharmaceuticals, Inc. |
2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases
|
|
ES2622493T3
(es)
|
2006-02-24 |
2017-07-06 |
Rigel Pharmaceuticals, Inc. |
Composiciones y métodos para la inhibición de la ruta de JAK
|
|
PE20120006A1
(es)
*
|
2006-05-15 |
2012-02-02 |
Boehringer Ingelheim Int |
Compuestos derivados de pirimidina como inhibidores de la quinasa aurora
|
|
RU2008152195A
(ru)
|
2006-06-15 |
2010-07-20 |
БЕРИНГЕР ИНГЕЛЬХАЙМ ИНТЕРНАЦИОНАЛЬ ГмбХ (DE) |
2-анилино-4-(гетероциклил)аминопиримидины, как ингибиторы протеинкиназы с-альфа
|
|
RU2008152193A
(ru)
|
2006-06-15 |
2010-07-20 |
Бёрингер Ингельхайм Интернациональ Гмбх (De) |
2-амино-4-аминоалкиленаминопиримидины
|
|
ES2528797T3
(es)
|
2006-08-21 |
2015-02-12 |
Genentech, Inc. |
Compuestos de aza-benzotiofenilo y métodos de uso
|
|
ES2555803T3
(es)
|
2006-10-23 |
2016-01-08 |
Cephalon, Inc. |
Fusión de derivados bicíclicos 2,4-diaminopirimidina como utilizar inhibidores ALK y c-Met
|
|
US20090048214A1
(en)
*
|
2006-11-15 |
2009-02-19 |
Rigel Pharmaceuticals, Inc |
Methods for Treating Renal Tumors Using 2, 4-Pyrimidinediamine Drug and Prodrug Compounds
|
|
NZ577197A
(en)
|
2006-12-08 |
2011-02-25 |
Irm Llc |
Pyrimidine compounds especially 4-phenylamino-2-arylamino-pyrimidine derivatives and compositions as protein kinase inhibitors
|
|
CN101563327A
(zh)
*
|
2006-12-19 |
2009-10-21 |
健泰科生物技术公司 |
嘧啶类激酶抑制剂
|
|
WO2008077885A2
(en)
*
|
2006-12-22 |
2008-07-03 |
Boehringer Ingelheim International Gmbh |
2- [(phenylamino) -pyrimidin-4ylamin0] -cyclopentane carboxamide derivatives and related compounds as inhibitors of kinases of the cell cycle for the treatment of cancer
|
|
BRPI0721138A2
(pt)
|
2006-12-22 |
2014-04-01 |
Hoffmann La Roche |
Derivados de espiro-piperidina
|
|
DE102007010801A1
(de)
|
2007-03-02 |
2008-09-04 |
Bayer Cropscience Ag |
Diaminopyrimidine als Fungizide
|
|
US7834024B2
(en)
|
2007-03-26 |
2010-11-16 |
Rigel Pharmaceuticals, Inc. |
Compositions and methods for inhibition of the JAK pathway
|
|
MY162157A
(en)
*
|
2007-04-16 |
2017-05-31 |
Abbott Lab |
Substituted indole mcl-1 inhibitors
|
|
WO2009003136A1
(en)
*
|
2007-06-26 |
2008-12-31 |
Rigel Pharmaceuticals, Inc. |
Substituted pyrimidine-2, 4 -diamines for treating cell proliferative disorders
|
|
CN101903357A
(zh)
|
2007-07-17 |
2010-12-01 |
里格尔药品股份有限公司 |
作为pkc抑制剂的环状胺取代的嘧啶二胺
|
|
WO2009087127A1
(en)
|
2008-01-11 |
2009-07-16 |
F. Hoffmann-La Roche Ag |
Modulators for amyloid beta
|
|
JP5328816B2
(ja)
|
2008-02-22 |
2013-10-30 |
エフ．ホフマン−ラ ロシュ アーゲー |
アミロイドβの調節薬
|
|
US20100155402A1
(en)
*
|
2008-02-27 |
2010-06-24 |
Pwp Industries, Inc. |
Display and storage container
|
|
MX2010010968A
(es)
*
|
2008-04-07 |
2010-10-26 |
Irm Llc |
Compuestos y composiciones como inhibidores de cinasa de proteina.
|
|
MX353308B
(es)
|
2008-05-21 |
2018-01-08 |
Ariad Pharma Inc |
Derivados fosforosos como inhibidores de cinasa.
|
|
US9273077B2
(en)
|
2008-05-21 |
2016-03-01 |
Ariad Pharmaceuticals, Inc. |
Phosphorus derivatives as kinase inhibitors
|
|
AU2009262198B2
(en)
*
|
2008-06-25 |
2012-09-27 |
Irm Llc |
Pyrimidine derivatives as kinase inhibitors
|
|
NZ603525A
(en)
|
2008-06-27 |
2015-02-27 |
Celgene Avilomics Res Inc |
Pyrimidine based compound and uses thereof
|
|
AU2013202496B2
(en)
*
|
2008-06-27 |
2016-08-04 |
Celgene Car Llc |
Heteroaryl compounds and uses thereof
|
|
US11351168B1
(en)
|
2008-06-27 |
2022-06-07 |
Celgene Car Llc |
2,4-disubstituted pyrimidines useful as kinase inhibitors
|
|
US8338439B2
(en)
|
2008-06-27 |
2012-12-25 |
Celgene Avilomics Research, Inc. |
2,4-disubstituted pyrimidines useful as kinase inhibitors
|
|
ES2426096T3
(es)
|
2008-07-01 |
2013-10-21 |
Genentech, Inc. |
Derivados de isoindolona como inhibidores de la quinasa MEK y métodos de utilización
|
|
US8841462B2
(en)
|
2008-07-01 |
2014-09-23 |
Robert A. Heald |
Bicyclic heterocycles as MEK kinase inhibitors
|
|
EP2161259A1
(de)
|
2008-09-03 |
2010-03-10 |
Bayer CropScience AG |
4-Halogenalkylsubstituierte Diaminopyrimidine als Fungizide
|
|
WO2010040661A1
(en)
|
2008-10-09 |
2010-04-15 |
F. Hoffmann-La Roche Ag |
Modulators for amyloid beta
|
|
AU2009312856A1
(en)
|
2008-11-10 |
2010-05-14 |
F. Hoffmann-La Roche Ag |
Heterocyclic gamma secretase modulators
|
|
RU2535032C2
(ru)
|
2008-12-22 |
2014-12-10 |
Милленниум Фармасьютикалз, Инк. |
Сочетание ингибиторов аврора киназы и анти-cd 20 антител
|
|
JP5815411B2
(ja)
|
2008-12-30 |
2015-11-17 |
ライジェル ファーマシューティカルズ， インコーポレイテッド |
ピリミジンジアミンキナーゼ阻害剤
|
|
JP5781942B2
(ja)
*
|
2009-01-14 |
2015-09-24 |
ライジェル ファーマシューティカルズ， インコーポレイテッド |
２，４−ピリミジンジアミン化合物を用いた炎症性障害の治療法
|
|
JP5603881B2
(ja)
*
|
2009-01-15 |
2014-10-08 |
ライジェル ファーマシューティカルズ， インコーポレイテッド |
プロテインキナーゼｃ阻害剤とその使用
|
|
JP5781943B2
(ja)
*
|
2009-01-21 |
2015-09-24 |
ライジェル ファーマシューティカルズ， インコーポレイテッド |
炎症性疾患、自己免疫疾患または増殖性疾患の治療に有用なｎ２−（３−ピリジルまたはフェニル）−ｎ４−（４−ピペリジル）−２，４−ピリミジンジアミン誘導体
|
|
US20110071158A1
(en)
*
|
2009-03-18 |
2011-03-24 |
Boehringer Ingelheim International Gmbh |
New compounds
|
|
US9908884B2
(en)
|
2009-05-05 |
2018-03-06 |
Dana-Farber Cancer Institute, Inc. |
EGFR inhibitors and methods of treating disorders
|
|
CN106420756A
(zh)
*
|
2009-07-28 |
2017-02-22 |
里格尔药品股份有限公司 |
抑制jak途径的组合物和方法
|
|
KR101726444B1
(ko)
|
2009-08-31 |
2017-04-12 |
스미또모 가가꾸 가부시키가이샤 |
수지, 레지스트 조성물 및 레지스트 패턴의 제조 방법
|
|
JP5681723B2
(ja)
|
2009-11-20 |
2015-03-11 |
ライジェル ファーマシューティカルズ， インコーポレイテッド |
２，４−ピリミジンジアミン化合物およびそのプロドラッグならびにそれらの使用
|
|
EP2507227B1
(en)
*
|
2009-12-01 |
2014-10-08 |
Rigel Pharmaceuticals, Inc. |
Tetrazolones as protein kinase c inhibitors and uses thereof
|
|
US8486096B2
(en)
*
|
2010-02-11 |
2013-07-16 |
Ethicon Endo-Surgery, Inc. |
Dual purpose surgical instrument for cutting and coagulating tissue
|
|
US8486967B2
(en)
|
2010-02-17 |
2013-07-16 |
Hoffmann-La Roche Inc. |
Heteroaryl substituted piperidines
|
|
CA2792278C
(en)
|
2010-04-13 |
2019-05-14 |
Rigel Pharmaceuticals, Inc. |
2,4-pyrimidinediamine compounds and prodrugs thereof and their uses
|
|
US8927547B2
(en)
|
2010-05-21 |
2015-01-06 |
Noviga Research Ab |
Pyrimidine derivatives
|
|
EP2395001A1
(en)
*
|
2010-05-21 |
2011-12-14 |
Chemilia AB |
Novel pyrimidine derivatives
|
|
ES2577829T3
(es)
|
2010-06-04 |
2016-07-19 |
F. Hoffmann-La Roche Ag |
Derivados de aminopirimidina como moduladores de la LRRK2
|
|
JP6035238B2
(ja)
*
|
2010-07-21 |
2016-11-30 |
ライジェル ファーマシューティカルズ， インコーポレイテッド |
プロテインキナーゼｃ阻害剤およびその使用
|
|
KR101841000B1
(ko)
|
2010-07-28 |
2018-03-22 |
스미또모 가가꾸 가부시키가이샤 |
포토레지스트 조성물
|
|
MX336875B
(es)
*
|
2010-08-10 |
2016-02-04 |
Celgene Avilomics Res Inc |
Sal de besilato de un inhibidor de tirosina cinasa de bruton (btk).
|
|
JP6195692B2
(ja)
|
2010-08-30 |
2017-09-13 |
住友化学株式会社 |
レジスト組成物及びレジストパターンの製造方法並びに新規化合物及び樹脂
|
|
WO2012061303A1
(en)
|
2010-11-01 |
2012-05-10 |
Avila Therapeutics, Inc. |
Heteroaryl compounds and uses thereof
|
|
EP2635284B1
(en)
|
2010-11-01 |
2019-12-18 |
Celgene CAR LLC |
Heterocyclic compounds and uses thereof
|
|
WO2012064706A1
(en)
|
2010-11-10 |
2012-05-18 |
Avila Therapeutics, Inc. |
Mutant-selective egfr inhibitors and uses thereof
|
|
NO2638031T3
(https=)
|
2010-11-10 |
2018-03-10 |
|
|
|
EP2489663A1
(en)
|
2011-02-16 |
2012-08-22 |
Almirall, S.A. |
Compounds as syk kinase inhibitors
|
|
JP5898521B2
(ja)
|
2011-02-25 |
2016-04-06 |
住友化学株式会社 |
レジスト組成物及びレジストパターンの製造方法
|
|
JP5947053B2
(ja)
|
2011-02-25 |
2016-07-06 |
住友化学株式会社 |
レジスト組成物及びレジストパターンの製造方法
|
|
JP5898520B2
(ja)
|
2011-02-25 |
2016-04-06 |
住友化学株式会社 |
レジスト組成物及びレジストパターンの製造方法
|
|
JP6034026B2
(ja)
|
2011-02-25 |
2016-11-30 |
住友化学株式会社 |
レジスト組成物及びレジストパターンの製造方法
|
|
JP5829940B2
(ja)
|
2011-02-25 |
2015-12-09 |
住友化学株式会社 |
レジスト組成物及びレジストパターンの製造方法
|
|
JP6034025B2
(ja)
|
2011-02-25 |
2016-11-30 |
住友化学株式会社 |
レジスト組成物及びレジストパターンの製造方法
|
|
JP5829939B2
(ja)
|
2011-02-25 |
2015-12-09 |
住友化学株式会社 |
レジスト組成物及びレジストパターンの製造方法
|
|
JP5947051B2
(ja)
|
2011-02-25 |
2016-07-06 |
住友化学株式会社 |
レジスト組成物及びレジストパターンの製造方法
|
|
JP5829941B2
(ja)
|
2011-02-25 |
2015-12-09 |
住友化学株式会社 |
レジスト組成物及びレジストパターンの製造方法
|
|
DK2688883T3
(en)
|
2011-03-24 |
2016-09-05 |
Noviga Res Ab |
pyrimidine
|
|
WO2012135641A2
(en)
|
2011-03-30 |
2012-10-04 |
H. Lee Moffitt Cancer Center And Research Institute |
Aurora kinase inhibitors and methods of making and using thereof
|
|
EP2704572B1
(en)
|
2011-05-04 |
2015-12-30 |
Ariad Pharmaceuticals, Inc. |
Compounds for inhibiting cell proliferation in egfr-driven cancers
|
|
CA2834062A1
(en)
|
2011-05-10 |
2012-11-15 |
Merck Sharp & Dohme Corp. |
Pyridyl aminopyridines as syk inhibitors
|
|
EP2706853B1
(en)
|
2011-05-10 |
2017-06-14 |
Merck Sharp & Dohme Corp. |
Aminopyrimidines as syk inhibitors
|
|
US9145391B2
(en)
|
2011-05-10 |
2015-09-29 |
Merck Sharp & Dohme Corp. |
Bipyridylaminopyridines as Syk inhibitors
|
|
JP5886696B2
(ja)
|
2011-07-19 |
2016-03-16 |
住友化学株式会社 |
レジスト組成物及びレジストパターンの製造方法
|
|
JP6013799B2
(ja)
|
2011-07-19 |
2016-10-25 |
住友化学株式会社 |
レジスト組成物及びレジストパターンの製造方法
|
|
JP6189020B2
(ja)
|
2011-07-19 |
2017-08-30 |
住友化学株式会社 |
レジスト組成物及びレジストパターンの製造方法
|
|
JP5912912B2
(ja)
|
2011-07-19 |
2016-04-27 |
住友化学株式会社 |
レジスト組成物及びレジストパターンの製造方法
|
|
JP6013797B2
(ja)
|
2011-07-19 |
2016-10-25 |
住友化学株式会社 |
レジスト組成物及びレジストパターンの製造方法
|
|
HRP20190186T4
(hr)
|
2011-07-28 |
2024-12-20 |
Rigel Pharmaceuticals, Inc. |
Nove formulacije (trimetoksifenilamino)pirimidinila
|
|
WO2013026914A1
(en)
|
2011-08-25 |
2013-02-28 |
F. Hoffmann-La Roche Ag |
Serine/threonine pak1 inhibitors
|
|
US9216173B2
(en)
|
2011-10-05 |
2015-12-22 |
Merck Sharp & Dohme Corp. |
2-Pyridyl carboxamide-containing spleen tyrosine kinase (SYK) inhibitors
|
|
EP2763975B1
(en)
|
2011-10-05 |
2016-04-06 |
Merck Sharp & Dohme Corp. |
3-pyridyl carboxamide-containing spleen tyrosine kinase (syk) inhibitors
|
|
WO2013052391A1
(en)
|
2011-10-05 |
2013-04-11 |
Merck Sharp & Dohme Corp. |
PHENYL CARBOXAMIDE-CONTAINING SPLEEN TYROSINE KINASE (Syk) INHIBITORS
|
|
US9364476B2
(en)
|
2011-10-28 |
2016-06-14 |
Celgene Avilomics Research, Inc. |
Methods of treating a Bruton's Tyrosine Kinase disease or disorder
|
|
CN104011050A
(zh)
|
2011-12-22 |
2014-08-27 |
霍夫曼-拉罗奇有限公司 |
作为丝氨酸/苏氨酸激酶抑制剂的2,4-二氨基-嘧啶衍生物
|
|
BR112014022790B1
(pt)
|
2012-03-15 |
2022-04-19 |
Celgene Car Llc |
Sais de um inibidor de quinase de receptor de fator do crescimento epidermal, composição farmacêutica e usos do mesmo
|
|
CA2866852C
(en)
|
2012-03-15 |
2020-12-29 |
Celgene Avilomics Research, Inc. |
Solid forms of an epidermal growth factor receptor kinase inhibitor
|
|
WO2013169401A1
(en)
|
2012-05-05 |
2013-11-14 |
Ariad Pharmaceuticals, Inc. |
Compounds for inhibiting cell proliferation in egfr-driven cancers
|
|
EP2863914B1
(en)
|
2012-06-20 |
2018-10-03 |
Merck Sharp & Dohme Corp. |
Pyrazolyl derivatives as syk inhibitors
|
|
EP2863913B1
(en)
|
2012-06-20 |
2018-09-12 |
Merck Sharp & Dohme Corp. |
Imidazolyl analogs as syk inhibitors
|
|
EP2863916B1
(en)
|
2012-06-22 |
2018-07-18 |
Merck Sharp & Dohme Corp. |
Substituted pyridine spleen tyrosine kinase (syk) inhibitors
|
|
EP2863915B1
(en)
|
2012-06-22 |
2017-12-06 |
Merck Sharp & Dohme Corp. |
SUBSTITUTED DIAZINE AND TRIAZINE SPLEEN TYROSINE KINASE (Syk) INHIBITORS
|
|
KR101446742B1
(ko)
*
|
2012-08-10 |
2014-10-01 |
한국화학연구원 |
Ｎ2,ｎ4-비스(4-(피페라진-1-일)페닐)피리미딘-2,4-디아민 유도체 또는 이의 약학적으로 허용가능한 염 및 이를 유효성분으로 함유하는 암의 예방 또는 치료용 약학적 조성물
|
|
US9353066B2
(en)
|
2012-08-20 |
2016-05-31 |
Merck Sharp & Dohme Corp. |
Substituted phenyl-Spleen Tyrosine Kinase (Syk) inhibitors
|
|
WO2014048065A1
(en)
|
2012-09-28 |
2014-04-03 |
Merck Sharp & Dohme Corp. |
Triazolyl derivatives as syk inhibitors
|
|
EP2931281B1
(en)
|
2012-12-12 |
2018-01-17 |
Merck Sharp & Dohme Corp. |
Amino-pyrimidine-containing spleen tyrosine kinase inhibitors
|
|
US9126950B2
(en)
|
2012-12-21 |
2015-09-08 |
Celgene Avilomics Research, Inc. |
Heteroaryl compounds and uses thereof
|
|
EP2934525B1
(en)
|
2012-12-21 |
2019-05-08 |
Merck Sharp & Dohme Corp. |
Thiazole-substituted aminopyridines as spleen tyrosine kinase inhibitors
|
|
MX2015009952A
(es)
|
2013-02-08 |
2015-10-05 |
Celgene Avilomics Res Inc |
Inhibidores de cinasas reguladas por señales extracelulares (erk) y sus usos.
|
|
US9611283B1
(en)
|
2013-04-10 |
2017-04-04 |
Ariad Pharmaceuticals, Inc. |
Methods for inhibiting cell proliferation in ALK-driven cancers
|
|
EP2988749B1
(en)
|
2013-04-26 |
2019-08-14 |
Merck Sharp & Dohme Corp. |
Thiazole-substituted aminopyrimidines as spleen tyrosine kinase inhibitors
|
|
WO2014176210A1
(en)
|
2013-04-26 |
2014-10-30 |
Merck Sharp & Dohme Corp. |
Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors
|
|
US9492471B2
(en)
|
2013-08-27 |
2016-11-15 |
Celgene Avilomics Research, Inc. |
Methods of treating a disease or disorder associated with Bruton'S Tyrosine Kinase
|
|
EP3076963A4
(en)
|
2013-12-06 |
2017-09-13 |
Millennium Pharmaceuticals, Inc. |
Combination of aurora kinase inhibitors and anti-cd30 antibodies
|
|
WO2015095444A1
(en)
|
2013-12-20 |
2015-06-25 |
Merck Sharp & Dohme Corp. |
Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors
|
|
US9822107B2
(en)
|
2013-12-20 |
2017-11-21 |
Merck Sharp & Dohme Corp. |
Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors
|
|
US9415049B2
(en)
|
2013-12-20 |
2016-08-16 |
Celgene Avilomics Research, Inc. |
Heteroaryl compounds and uses thereof
|
|
WO2015094997A1
(en)
|
2013-12-20 |
2015-06-25 |
Merck Sharp & Dohme Corp. |
Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors
|
|
WO2015138273A1
(en)
|
2014-03-13 |
2015-09-17 |
Merck Sharp & Dohme Corp. |
2-pyrazine carboxamides as spleen tyrosine kinase inhibitors
|
|
CN105017159B
(zh)
*
|
2014-04-28 |
2019-05-17 |
四川大学 |
5-氟-2,4-二取代氨基嘧啶衍生物及其制备方法和用途
|
|
WO2016022460A1
(en)
*
|
2014-08-03 |
2016-02-11 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Potent dual brd4-kinase inhibitors as cancer therapeutics
|
|
EP3179858B1
(en)
|
2014-08-13 |
2019-05-15 |
Celgene Car Llc |
Forms and compositions of an erk inhibitor
|
|
WO2016029002A2
(en)
*
|
2014-08-22 |
2016-02-25 |
Clovis Oncology, Inc. |
Growth factor receptor inhibitors
|
|
WO2017015316A1
(en)
|
2015-07-21 |
2017-01-26 |
Millennium Pharmaceuticals, Inc. |
Administration of aurora kinase inhibitor and chemotherapeutic agents
|
|
WO2017066428A1
(en)
|
2015-10-13 |
2017-04-20 |
H. Lee Moffitt Cancer Center & Research Institute, Inc. |
Brd4-kinase inhibitors as cancer therapeutics
|
|
WO2017156527A1
(en)
*
|
2016-03-11 |
2017-09-14 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Aurora kinase and janus kinase inhibitors for prevention of graft versus host disease
|
|
US20200039998A1
(en)
*
|
2016-12-19 |
2020-02-06 |
Epizyme, Inc. |
Amine-substituted heterocyclic compounds as ehmt2 inhibitors and methods of use thereof
|
|
CA3056590A1
(en)
*
|
2017-02-15 |
2018-08-23 |
Nanyang Technological University |
Compounds for treating tuberculosis
|
|
CN110621316B
(zh)
|
2017-04-21 |
2024-01-26 |
Epizyme股份有限公司 |
用ehmt2抑制剂进行的组合疗法
|
|
WO2019099311A1
(en)
*
|
2017-11-19 |
2019-05-23 |
Sunshine Lake Pharma Co., Ltd. |
Substituted heteroaryl compounds and methods of use
|
|
WO2019195658A1
(en)
|
2018-04-05 |
2019-10-10 |
Dana-Farber Cancer Institute, Inc. |
Sting levels as a biomarker for cancer immunotherapy
|
|
US11518758B2
(en)
|
2019-05-10 |
2022-12-06 |
Deciphera Pharmaceuticals, Llc |
Heteroarylaminopyrimidine amide autophagy inhibitors and methods of use thereof
|
|
PE20220597A1
(es)
|
2019-05-10 |
2022-04-22 |
Deciphera Pharmaceuticals Llc |
Inhibidores de la autofagia de fenilaminopirimidina amida y metodos de uso de estos
|
|
PE20221083A1
(es)
|
2019-06-17 |
2022-07-05 |
Deciphera Pharmaceuticals Llc |
Inhibidores de la autofagia de la amida aminopirimidina y sus metodos de uso
|
|
EP3994132A1
(en)
|
2019-07-03 |
2022-05-11 |
Sumitomo Dainippon Pharma Oncology, Inc. |
Tyrosine kinase non-receptor 1 (tnk1) inhibitors and uses thereof
|
|
US20220305048A1
(en)
|
2019-08-26 |
2022-09-29 |
Dana-Farber Cancer Institute, Inc. |
Use of heparin to promote type 1 interferon signaling
|
|
US12084453B2
(en)
|
2021-12-10 |
2024-09-10 |
Incyte Corporation |
Bicyclic amines as CDK12 inhibitors
|
|
CN115304550A
(zh)
*
|
2022-07-25 |
2022-11-08 |
南通大学 |
哌嗪苯基氨基取代的嘧啶氨基酸衍生物及制备方法与应用
|
|
CN115232076A
(zh)
*
|
2022-07-25 |
2022-10-25 |
南通大学 |
苯氨基取代的嘧啶氨基酸衍生物及其制备方法与应用
|
|
CN115141150B
(zh)
*
|
2022-07-25 |
2024-04-26 |
南通大学 |
2,4,5-三取代嘧啶羟胺酰衍生物及其制备方法与应用
|
|
CN115304551A
(zh)
*
|
2022-07-25 |
2022-11-08 |
南通大学 |
2-((4-吗啉苯基)氨基)嘧啶氨基酸衍生物及其制备方法与应用
|
|
CN119431398A
(zh)
*
|
2023-07-31 |
2025-02-14 |
中国科学院上海有机化学研究所 |
R406及其衍生物协同trail的抗肿瘤应用
|